Lorenzo Piemonti
@piemontil.bsky.social
Director Diabetes Research Institute and Clinic Unit of Regenerative Medicine and Organ Transplants, Professor of endocrinology Universita Vita-Salute San Raffaele, Milan, Italy
#ESPEESE2025 has just wrapped up in Copenhagen!
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
May 13, 2025 at 2:06 PM
#ESPEESE2025 has just wrapped up in Copenhagen!
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
Bringing new therapy to patients needs strong clinical trials and regulatory alignment. Europe is updating GCP guidelines (ICH E6(R3)) to boost efficiency while ensuring safety and transparency
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
February 20, 2025 at 11:24 AM
Bringing new therapy to patients needs strong clinical trials and regulatory alignment. Europe is updating GCP guidelines (ICH E6(R3)) to boost efficiency while ensuring safety and transparency
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop